Galantamine Effects on Cognitive Function in Abstinent Cocaine Users
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
To evaluate galantamine's effects on cognitive performance in abstinent cocaine users.
Galantamine, a medication approved for treatment of Alzheimer's disease, is an acetylcholine
esterase inhibitor. Galantamine also directly potentiates nicotine receptors. Both of these
effects may result in improved cognitive performance in a group of subjects known to have
impaired performance in various cognitive tasks.